Refine your search with filters

All-Materials All
Congress-AbstractsCongress Abstracts
Tools-SkillsTools & Skills
PublicationsPublications
Congress-SlidesCongress Presentations
Videos-PodcastsVideos & Podcasts

Quicksearch


Notice: Undefined property: stdClass::$content in /home/elearec6/www.gtntest-e-learning.ecco-ibd.eu/moodleneu/blocks/exalib/adv_search.php on line 643

Notice: Undefined property: stdClass::$content in /home/elearec6/www.gtntest-e-learning.ecco-ibd.eu/moodleneu/blocks/exalib/adv_search.php on line 644

Notice: Undefined property: stdClass::$icfcat in /home/elearec6/www.gtntest-e-learning.ecco-ibd.eu/moodleneu/blocks/exalib/renderer.php on line 255

Notice: Undefined variable: catt in /home/elearec6/www.gtntest-e-learning.ecco-ibd.eu/moodleneu/blocks/exalib/renderer.php on line 269
DOP25: Clinical outcomes of COVID-19 and Impact on Disease Course in Patients with Inflammatory Bowel DiseaseECCO'22
Year: 2022
Authors: Wetwittayakhlang, P.(1);Albader, F.(2);Golovics, P.(1);Drügg Hahn, G.(1);Bessissow, T.(1); Bitton, A.(1); Afif, W.(1);Wild, G.(1);LakatosPhD, P.L.(1); Inflammatory bowel disease McGill University Health Centre
(1)Mcgill University Health Center, IBD Centre, Montréal, Canada;(2)Mcgill University Health Center, Division of Internal Medicine, Montréal, Canada;

Notice: Undefined property: stdClass::$icfcat in /home/elearec6/www.gtntest-e-learning.ecco-ibd.eu/moodleneu/blocks/exalib/renderer.php on line 255

Notice: Undefined variable: catt in /home/elearec6/www.gtntest-e-learning.ecco-ibd.eu/moodleneu/blocks/exalib/renderer.php on line 269
DOP26: COVID-19 vaccine effectiveness in Inflammatory Bowel Disease patients on tumor-necrosis factor inhibitors: Real world data from a mass-vaccination campaignECCO'22
Year: 2022
Authors: Lev Zion, R.(1);Focht, G.(1);Lujan, R.(1);Mendelovici, A.(1);Friss, C.(1);Greenfeld, S.(2);Kariv, R.(3);Ben-Tov, A.(4,5);Matz, E.(6);Nevo, D.(7);Barak-Corren, Y.(8);Dotan, I.(9);Turner, D.(10);
(1)Shaare Zedek Medical Center, Department of Pediatric Gastroenterology, Jerusalem, Israel;(2)Maccabi Health Services and the Sackler Faculty of Medicine- Tel Aviv University, Medical Informatics, Tel-Aviv, Israel;(3)Maccabi Health Services and the Sackler Faculty of Medicine- Tel Aviv University, Gastroenterology, Tel-Aviv, Israel;(4)Maccabi Health Services and the Sackler Faculty of Medicine- Tel Aviv University, Institute for Research & Innovation, Tel-Aviv, Israel;(5)Dana-Dwek Children's Hospital- Tel-Aviv Sourasky Medical Center, Pediatric Gastroenterology, Tel-Aviv, Israel;(6)Leumit Health Services, Community Medicine, Tel-Aviv, Israel;(7)Tel-Aviv University, Department of Statistics and Operations Research, Tel-Aviv, Israel;(8)Boston Children's Hospital, Predictive Medicine Group, Boston, United States;(9)Rabin Medical Center and the Sackler Faculty of Medicine- Tel Aviv University, Gastroenterology, Petah Tikva, Israel;(10)Shaare Zedek Medical Center and the Hebrew University of Jerusalem, Department of Pediatric Gastroenterology, Jerusalem, Israel;

Notice: Undefined property: stdClass::$icfcat in /home/elearec6/www.gtntest-e-learning.ecco-ibd.eu/moodleneu/blocks/exalib/renderer.php on line 255

Notice: Undefined variable: catt in /home/elearec6/www.gtntest-e-learning.ecco-ibd.eu/moodleneu/blocks/exalib/renderer.php on line 269
DOP27: Humoral immune response after SARS-CoV-2 vaccination in patients with immune-mediated inflammatory diseases treated with immunosuppressive therapy - a Target to B! studyECCO'22
Year: 2022
Authors: Volkers , A.(1);Wieske , L.(2);van Dam , K.(2);Steenhuis , M.(3);Stalman , E.(2);Kummer , L.(2);van Kempen , Z.(4);Killestein , J.(4);Tas , S.(5);Boekel , L.(6);Wolbink , G.(6);Takkenberg , B.(1);Spuls , P.(7);Bosma , A.(7);Rutgers , B.(8);Verschuuren , J.(9);van Ouwerkerk , L.(10);van der Woude , D.(10);van Paassen , P.(11);Busch , M.(11);Brusse , E.(12);Hijnen , D.(13);ten Brinke , A.(3);Verstegen , N.(3);D'Haens , G.(1);van Ham , M.(3);Kuijpers , T.(14);Rispens , T.(3);Löwenberg , M.(1);Eftimov , F.(2); on behalf of the T2B! immunity against SARS-CoV-2 study group
(1)Amsterdam UMC- location AMC, Gastroenterology and Hepatology, Amsterdam, The Netherlands;(2)Amsterdam UMC- location AMC, Department of Neurology and Neurophysiology, Amsterdam, The Netherlands;(3)Sanquin, Department of immunopathology, Amsterdam, The Netherlands;(4)Amsterdam UMC- location VU University medical center, Department of Neurology, Amsterdam, The Netherlands;(5)Amsterdam UMC, Department of Rheumatology and Clinical Immunology, Amsterdam, The Netherlands;(6)Amsterdam Rheumatology and immunology Center- location Reade, Department of Rheumatology, Amsterdam, The Netherlands;(7)Amsterdam UMC- location Academic Medical Center, Department of Dermatology, Amsterdam, The Netherlands;(8)University Medical Center Groningen, Department of Rheumatology and Clinical Immunology, Groningen, The Netherlands;(9)Leiden University Medical Center, Department of Neurology, Leiden, The Netherlands;(10)Leiden University Medical Center, Department of Rheumatology, Leiden, The Netherlands;(11)Maastricht University Medical Center, Department of Nephrology and Clinical Immunology, Maastricht, The Netherlands;(12)Erasmus MC University Medical Center, Department of Neurology, Rotterdam, The Netherlands;(13)Erasmus MC University Medical Center, Department of Dermatology, Rotterdam, The Netherlands;(14)Amsterdam UMC- location AMC, Department of Pediatric Immunology- Rheumatology and Infectious Disease, Amsterdam, The Netherlands;

Notice: Undefined property: stdClass::$icfcat in /home/elearec6/www.gtntest-e-learning.ecco-ibd.eu/moodleneu/blocks/exalib/renderer.php on line 255

Notice: Undefined variable: catt in /home/elearec6/www.gtntest-e-learning.ecco-ibd.eu/moodleneu/blocks/exalib/renderer.php on line 269
DOP28: Venous thromboembolism following discharge from hospital in patients admitted for Inflammatory Bowel DiseaseECCO'22
Year: 2022
Authors: Harvey, P.(1);Coupland, B.(2);Mytton, J.(2);Trudgill, N.(3);De Silva, S.(4);
(1)The Royal Wolverhampton NHS trust, Department of Gastroenterology, Wolverhampton, United Kingdom;(2)University Hospital Birmingham, Healthcare Informatics, Birmingham, United Kingdom;(3)Sandwell and West Birmingham NHS Trust, Gastroenterology, Birmingham, United Kingdom;(4)Dudley Group NHS Trust, Gastroenterology, Birmingham, United Kingdom;

Notice: Undefined property: stdClass::$icfcat in /home/elearec6/www.gtntest-e-learning.ecco-ibd.eu/moodleneu/blocks/exalib/renderer.php on line 255

Notice: Undefined variable: catt in /home/elearec6/www.gtntest-e-learning.ecco-ibd.eu/moodleneu/blocks/exalib/renderer.php on line 269
DOP29: A novel predictive scoring system of venous thromboembolism after surgery for Inflammatory Bowel Disease: A NSQIP-IBD registry analysisECCO'22
Year: 2022
Authors: Cheong, J.Y.(1);Connelly, T.(1);Prien, C.(1);Jia, X.(1);Valente, M.(1);Bhama, A.(1);Lightner, A.(1);HolubarMD- MS, S.(1);
(1)Cleveland Clinic, Department of Colon & Rectal Surgery, Cleveland, United States;

Notice: Undefined property: stdClass::$icfcat in /home/elearec6/www.gtntest-e-learning.ecco-ibd.eu/moodleneu/blocks/exalib/renderer.php on line 255

Notice: Undefined variable: catt in /home/elearec6/www.gtntest-e-learning.ecco-ibd.eu/moodleneu/blocks/exalib/renderer.php on line 269
DOP30: Long-term outcomes of Crohn’s perianal fistulas treatment: anti-TNF with surgical closure versus anti-TNF alone (PISA-II) - A patient preference RCTECCO'22
Year: 2022
Authors: Meima - van PraagMD, E.(1);Stoker, J.(2);D'Haens, G.(3);Gecse, K.(4);Dijkgraaf, M.(5);Bemelman, W.(1);Buskens, C.(1);
(1)Amsterdam UMC, Surgery, Amsterdam, The Netherlands;(2)Amsterdam UMC, Radiology and Nuclear Medicine, Amsterdam, The Netherlands;(3)Amsterdam UMC, Gastroenterology and Hepatology, Gastroenterology and Hepatology, The Netherlands;(4)Amsterdam UMC, Gastroenterology and Hepatology, Amsterdam, The Netherlands;(5)Amsterdam UMC, Clinical Epidemiology- Biostatistics and Bioinformatics, Amsterdam, The Netherlands;

Notice: Undefined property: stdClass::$icfcat in /home/elearec6/www.gtntest-e-learning.ecco-ibd.eu/moodleneu/blocks/exalib/renderer.php on line 255

Notice: Undefined variable: catt in /home/elearec6/www.gtntest-e-learning.ecco-ibd.eu/moodleneu/blocks/exalib/renderer.php on line 269
DOP31: Efficacy and safety of bone marrow-derived mesenchymal stem cells in refractory perianal fistulae in Crohn’s Disease: Results from a prospective monocentric studyECCO'22
Year: 2022
Authors: Reenaers Dr, C.(1);Vieujean , S.(1);Coimbra , C.(2);Gillard , R.(3);Meunier , P.(3);Boutaffala , L.(1);Louis , E.(1);
(1)CHU Liège- Sart Tilman, Department of Gastroenterology, Liège, Belgium;(2)CHU Liège- Sart Tilman, Department of abdominal surgery, Liège, Belgium;(3)CHU Liège- Sart Tilman, Department of radiology, Liège, Belgium;

Notice: Undefined property: stdClass::$icfcat in /home/elearec6/www.gtntest-e-learning.ecco-ibd.eu/moodleneu/blocks/exalib/renderer.php on line 255

Notice: Undefined variable: catt in /home/elearec6/www.gtntest-e-learning.ecco-ibd.eu/moodleneu/blocks/exalib/renderer.php on line 269
DOP32: Biologic treatment does not reduce the risk of postoperative peristomal pyoderma gangrenosum in Crohn’s Disease patientsECCO'22
Year: 2022
Authors: Iesalnieks, I.(1);
(1)Evangelisches Krankenhaus Kalk, Department of surgery, Cologne, Germany;

Notice: Undefined property: stdClass::$icfcat in /home/elearec6/www.gtntest-e-learning.ecco-ibd.eu/moodleneu/blocks/exalib/renderer.php on line 255

Notice: Undefined variable: catt in /home/elearec6/www.gtntest-e-learning.ecco-ibd.eu/moodleneu/blocks/exalib/renderer.php on line 269
DOP33: Role of adherent and invasive E. coli in Crohn’s Disease: Lessons from the postoperative recurrence modelECCO'22
Year: 2022
Authors: Buisson, A.(1);Sokol, H.(2);Hammoudi, N.(3);Nancey, S.(4);Treton, X.(5);Nachury, M.(6);Fumery, M.(7);Hébuterne, X.(8);Rodrigues, M.(9);Hugot, J.P.(10);Boschetti, G.(4);Stefanescu, C.(5);Wils , P.(6);Seksik, P.(2);Le Bourhis, L.(3);Bezault, M.(11);Sauvanet, P.(9);Pereira, B.(12);Allez, M.(3);Barnich, N.(9);
(1)University Hospital Estaing, Department of Gastroenterology- IBD Unit, Clermont-Ferrand, France;(2)AP-HP Saint-Antoine Hospital, IBD Unit, Paris, France;(3)AP-HP Saint-Louis Hospital, IBD Unit, Paris, France;(4)HCL-Lyon Sud, IBD Unit, Lyon, France;(5)AP-HP Beaujon Hospital, IBD Unit, Paris, France;(6)CHRU Lille, IBD Unit, Lille, France;(7)CHU Amiens, IBD Unit, Amiens, France;(8)CHU Nice, IBD Unit, Nice, France;(9)Université Clermont Auvergne, M2iSH, Clermont--Ferrand, France;(10)Centre de recherche sur l’inflammation- INSERM UMR 1149- Assistance Publique-Hôpitaux de Paris- Université de Paris, IBD Unit, Paris, France;(11)REMIND group, Administrative staff, Paris, France;(12)University Hospital Estaing, DRCI- Statistics Unit, Clermont-Ferrand, France;REMIND study group

Notice: Undefined property: stdClass::$icfcat in /home/elearec6/www.gtntest-e-learning.ecco-ibd.eu/moodleneu/blocks/exalib/renderer.php on line 255

Notice: Undefined variable: catt in /home/elearec6/www.gtntest-e-learning.ecco-ibd.eu/moodleneu/blocks/exalib/renderer.php on line 269
DOP34: Comparison of the risk of clinical recurrence after ileocolonic resection for Crohn's Disease for modified Rutgeerts' score i2a and i2b categories: Individual patient data meta-analysisECCO'22
Year: 2022
Authors: Riviere, P.(1);Pekow, J.(2);Hammoudi, N.(3);Wils, P.(4);De Cruz, P.(5);Wang, C.(6);Mañosa, M.(7);Ollech, J.(2);Allez, M.(3);Nachury, M.(4);Kamm, M.(5);Maya, A.(2);Ferrante, M.(8);Buisson, A.(9);Singh, S.(10);Laharie, D.(1);Momar, D.(11);Fumery, M.(12);
(1)Bordeaux University Hospital, Gastroenterology unit, Pessac, France;(2)University of Chicago, Gastroenterology, Chicago, United States;(3)Hôpital Saint-Louis, Gastroenterology, Paris, France;(4)Lille University Hospital, Gastroenterology, Lille, France;(5)The Austin Hospital, Gastroenterology, Melbourne, Australia;(6)Mount Sinai Hospital, Gastroenterology, New York, United States;(7)Hospital Germans Trias, Gastroenterology, Badalona, Spain;(8)Leuven University Hospitals, Gastroenterology, Leuven, Belgium;(9)Clermont Ferrand University Hospitals, Gastroenterology, Clermont Ferrand, France;(10)UC San Diego Health, Gastroenterology, San Diego, United States;(11)Amiens University Hospitals, Statistics, Amiens, France;(12)Amiens University Hospitals, Gastroenterology, Amiens, France;

Notice: Undefined property: stdClass::$icfcat in /home/elearec6/www.gtntest-e-learning.ecco-ibd.eu/moodleneu/blocks/exalib/renderer.php on line 255

Notice: Undefined variable: catt in /home/elearec6/www.gtntest-e-learning.ecco-ibd.eu/moodleneu/blocks/exalib/renderer.php on line 269
DOP35: Increasing incidence of pouchitis among patients undergoing ileal pouch-anal anastomosis between 1996 and 2018: A population-based Danish cohort studyECCO'22
Year: 2022
Authors: Barnes, E.(1);Allin, K.(2);Iversen, A.(2);Herfarth, H.(1);Jess, T.(2);
(1)University of North Carolina at Chapel Hill, Division of Gastroenterology and Hepatology, Chapel Hill, United States;(2)Center for Molecular Prediction of Inflammatory Bowel Disease- Aalborg University, Department of Clinical Medicine, Copenhagen, Denmark;

Notice: Undefined property: stdClass::$icfcat in /home/elearec6/www.gtntest-e-learning.ecco-ibd.eu/moodleneu/blocks/exalib/renderer.php on line 255

Notice: Undefined variable: catt in /home/elearec6/www.gtntest-e-learning.ecco-ibd.eu/moodleneu/blocks/exalib/renderer.php on line 269
DOP36: Efficacy and safety of vedolizumab in patients with chronic active pouchitis refractory to anti-TNF therapy: Results of a retrospective multicenter studyECCO'22
Year: 2022
Authors: Sallette, M.(1);Bouhnik, Y.(2);Nachury, M.(3);Bellanger, C.(4);Laharie, D.(5);Amiot, A.(6);Peyrin-Biroulet, L.(7);Roblin, X.(8);Altwegg, R.(9);Buisson, A.(10);Reenaers, C.(11);Bouguen, G.(12);Vuitton, L.(13);Bourreille, A.(14);Gilletta, C.(15);Serrero, M.(16);Hébuterne, X.(17);Filippi, J.(18); Groupe d'Etude Thérapeutique des Affections Inflammatoires du Tube Digestif (GETAID)
(1)Archet 2 University Hospital, Gastroenterology, Nice, France;(2)Beaujon University Hospital, Gastroenterology, Paris, France;(3)Lille University Hospital, Gastroenterology, Lille, France;(4)Kremlin Bicêtre Hospital, Gastroenterology, Paris, France;(5)Haut Lévêque Hospital, Gastroenterology, Bordeaux, France;(6)Henri Mondor University Hospital, Gastroenterology, Paris, France;(7)Nancy University Hospital, Gastroenterology, Nancy, France;(8)Saint Etienne University Hospital, Gastroenterology, Saint Etienne, France;(9)Montpellier University Hospital, Gastroenterology, Montpellier, France;(10)Clermont-Ferrand University Hospital, Gastroenteroogy, Clermont-Ferrand, France;(11)Liège University Hospital, Gastroenterology, Liège, Belgium;(12)Rennes University Hospital, Gastroenterology, Rennes, France;(13)Besançon University Hospital, Gastroenterology, Besançon, France;(14)Nantes University Hospital, Gastroenteroogy, Nantes, France;(15)Toulouse University Hospital, Gastroenterology, Toulouse, France;(16)Nord University Hospital, Gastroenterology, Marseille, France;(17)Archet 2 University Hospital, Gastroenterology, Nice, France;(18)Archet 2 Unversity Hospital, Gastroenterology, Nice, France;

Notice: Undefined property: stdClass::$icfcat in /home/elearec6/www.gtntest-e-learning.ecco-ibd.eu/moodleneu/blocks/exalib/renderer.php on line 255

Notice: Undefined variable: catt in /home/elearec6/www.gtntest-e-learning.ecco-ibd.eu/moodleneu/blocks/exalib/renderer.php on line 269
DOP37: Efficacy and safety of filgotinib in patients with Ulcerative Colitis stratified by age: Post hoc analysis of the phase 2b/3 SELECTION and SELECTIONLTE studiesECCO'22
Year: 2022
Authors: SCHREIBER, S.(1);Loftus Jr, E.V.(2);Maaser, C.(3);Danese, S.(4,5);Rudolph, C.(6);Jongen, R.(6);De Haas, A.(6);Oortwijn, A.(6);Vermeire, S.(7);
(1)Kiel University, Medicine I, Kiel, Germany;(2)Mayo Clinic College of Medicine and Science, Division of Gastroenterology and Hepatology, Rochester, United States;(3)Hospital Lüneburg, Outpatients Department of Gastroenterology, Lüneburg, Germany;(4)IRCCS Ospedale San Raffaele, Gastroenterology and Endoscopy, Milan, Italy;(5)Vita-Salute, San Raffaele University, Milan, Italy;(6)Galapagos, Nv, Leiden, The Netherlands;(7)University Hospitals Leuven, Department of Gastroenterology and Hepatology, Leuven, Belgium;

Notice: Undefined property: stdClass::$icfcat in /home/elearec6/www.gtntest-e-learning.ecco-ibd.eu/moodleneu/blocks/exalib/renderer.php on line 255

Notice: Undefined variable: catt in /home/elearec6/www.gtntest-e-learning.ecco-ibd.eu/moodleneu/blocks/exalib/renderer.php on line 269
DOP38: Upadacitinib Therapy Reduces Ulcerative Colitis Symptoms as Early as Day 1ECCO'22
Year: 2022
Authors: Vermeire, S.(1);Colombel, J.F.(2);Takeuchi, K.(3);Gao, X.(4);Panaccione, R.(5);Danese, S.(6);Dubinsky, M.(7);Schreiber, S.(8);Ilo, D.(9);Finney-Hayward, T.(9);Zhou, W.(9);Phillips, C.(9);Yao, X.(9);Zhou, Q.(9);Loftus, E.(10);
(1)University Hospital Leuven, none, Leuven, Belgium;(2)Icahn School of Medicine at Mount Sinai, none, New York City, United States;(3)Tsujinaka Hospital Kashiwanoha- Kashiwa, Division of Gastroenterology and Hepatology, Chiba, Japan;(4)The Sixth Affiliated Hospital of Sun Yat-sen University, Department of Gastroenterology, Guangzhou, China;(5)University of Calgary, Division of Gastroenterology and Hepatology, Alberta, Canada;(6)IRCCS Ospedale San Raffaele and University Vita-Salute San Raffaele, Department of Gastroenterology and Endoscopy, Milan, Italy;(7)Icahn School of Medicine at Mt Sinai, Department of Pediatric Gastroenterology, New York, United States;(8)University Hospital Schleswig-Holstein, none, Kiel, Germany;(9)AbbVie- Inc, none, North Chicago, United States;(10)Mayo Clinic College of Medicine, Division of Gastroenterology and Hepatology, Rochester, United States;

Notice: Undefined property: stdClass::$icfcat in /home/elearec6/www.gtntest-e-learning.ecco-ibd.eu/moodleneu/blocks/exalib/renderer.php on line 255

Notice: Undefined variable: catt in /home/elearec6/www.gtntest-e-learning.ecco-ibd.eu/moodleneu/blocks/exalib/renderer.php on line 269
DOP39: Effect of baseline disease characteristics on clinical outcomes in moderate-to-severe Ulcerative Colitis treated with upadacitinib: Results from a Phase 3 trials programmeECCO'22
Year: 2022
Authors: Higgins, P.(1);Colombel, J.F.(2);Reguiero, M.(3);Parkes, G.(4);Ilo, D.(5);Philips, C.(5);Yao, X.(6);Cheng, E.(6);Schreiber, S.(7);
(1)University of Michigan, Department of Internal Medicine, Ann Arbor, United States;(2)Icahn School of Medicine at Mount Sinai, Department of Gastroenterology, New York, United States;(3)Cleveland Clinic Foundation, Department of Gastroenterology and Hepatology, Cleveland, United States;(4)Royal London Hospital, Department of Gastroenterology, London, United Kingdom;(5)AbbVie Inc, Research and Development, North Chicago- Illinois, United States;(6)AbbVie Inc, Data & Statistical Sciences, North Chicago- Illinois, United States;(7)University Hospital Schleswig-Holstein, Department of Internal Medicine, Kiel, Germany;

Notice: Undefined property: stdClass::$icfcat in /home/elearec6/www.gtntest-e-learning.ecco-ibd.eu/moodleneu/blocks/exalib/renderer.php on line 255

Notice: Undefined variable: catt in /home/elearec6/www.gtntest-e-learning.ecco-ibd.eu/moodleneu/blocks/exalib/renderer.php on line 269
DOP40: Impact of corticosteroid usage on efficacy and safety outcomes in patients receiving upadacitinib for Ulcerative ColitisECCO'22
Year: 2022
Authors: Raine, T.(1);Ishiguro, Y.(2);Rubin, D.(3);Finney-Hayward, T.(4);Dapo, I.(5);Phillips, C.(5);Cheng, E.(6);Targownik, L.(7);Loftus- Jr., E.V.(8);
(1)Addenbrooke's Hospital- Cambridge University Hospitals, Department of Gastroenterology, Cambridge, United Kingdom;(2)Hirosaki General Medical Centre- National Hospital Organisation, Department of Clinical Research, Hirosaki, Japan;(3)The University of Chicago Medicine, Inflammatory Bowel Disease Center, Chicago, United States;(4)AbbVie Ltd., Gastroenterology, Maidenhead, United Kingdom;(5)AbbVie Ltd., Research and Development, North Chicago, United States;(6)AbbVie Ltd., Data & Statistical Science, North Chicago, United States;(7)Mount Sinai Hospital- University of Toronto, Division of Gastroenterology and Hepatology, Toronto, Canada;(8)Mayo Clinic College of Medicine, Division of Gastroenterology and Hepatology, Rochester, United States;

Notice: Undefined property: stdClass::$icfcat in /home/elearec6/www.gtntest-e-learning.ecco-ibd.eu/moodleneu/blocks/exalib/renderer.php on line 255

Notice: Undefined variable: catt in /home/elearec6/www.gtntest-e-learning.ecco-ibd.eu/moodleneu/blocks/exalib/renderer.php on line 269
DOP41: Efficacy and safety of extended induction treatment with upadacitinib 45 mg once daily followed by maintenance upadacitinib 15 or 30 mg once daily in patients with moderately to severely active Ulcerative ColitisECCO'22
Year: 2022
Authors: Vermeire, S.(1);Danese, S.(2);Zhou, W.(3);Klaff, J.(3);Ilo, D.(3);Yao, X.(4);Levy, G.(5);Higgins, P.D.R.(6);Loftus- Jr., E.V.(7);Panaccione, R.(8);
(1)University Hospital Leuven & KU Leuven, Gastroenterology & Hepatology, Leuven, Belgium;(2)IRCCS Ospedale San Raffaele and University Vita-Salute San Raffaele, Gastroenterology and Endoscopy, Milan, Italy;(3)AbbVie Inc., Research and Development, North Chicago- Illinois, United States;(4)AbbVie Inc., Data & Statistical Sciences, North Chicago- Illinois, United States;(5)AbbVie Inc., Pharmacovigilance & Patient Safety, North Chicago- Illinois, United States;(6)University of Michigan, Department of Medicine- Division of Gastroenterology, Ann Arbor- Michigan, United States;(7)Mayo Clinic- College of Medicine, Division of Gastroenterology and Hepatology, Rochester- Minnesota, United States;(8)University of Calgary, Inflammatory Bowel Disease Unit- Division of Gastroenterology and Hepatology, Calgary- Alberta, Canada;

Notice: Undefined property: stdClass::$icfcat in /home/elearec6/www.gtntest-e-learning.ecco-ibd.eu/moodleneu/blocks/exalib/renderer.php on line 255

Notice: Undefined variable: catt in /home/elearec6/www.gtntest-e-learning.ecco-ibd.eu/moodleneu/blocks/exalib/renderer.php on line 269
DOP42: Efficacy and safety of deucravacitinib, an oral, selective tyrosine kinase 2 inhibitor, in patients with moderately-to-severely active Ulcerative Colitis: 12-week results from the Phase 2 LATTICE-UC studyECCO'22
Year: 2022
Authors: Danese, S.(1);Panaccione, R.(2);D'Haens, G.(3);Peyrin-Biroulet, L.(4);Schreiber, S.(5);Kobayashi, T.(6);Gawdis-Wojnarska, B.(7);Korga, P.(8);Aguilar, H.(9);Sharkey, B.(10);Sreih, A.(11);Radosti, C.(10);Patel, A.(10);Canavan, J.(10);Rubin, D.(12);
(1)Humanitas Research Hospital, Inflammatory Bowel Diseases Center, Milan, Italy;(2)University of Calgary, Inflammatory Bowel Disease Clinic, Calgary- Alberta, Canada;(3)Amsterdam University Medical Centers, Inflammatory Bowel Disease Unit, Amsterdam, Netherlands Antilles;(4)Nancy University Hospital, Gastroenterology, Nancy, France;(5)University Hospital Schleswig-Holstein, Gastroenterology, Kiel, Germany;(6)Kitasato University Kitasato Institute Hospital, Gastroenterology, Tokyo, Japan;(7)Twoja Przychodnia-Szczecińskie Centrum Medyczne, Gastroenterology, Szczecin, Poland;(8)Centrum Medyczne KERmed, Gastroenterology, Bydgoszcz, Poland;(9)Louisiana Research Center, Gastroenterology, Shreveport, United States;(10)Bristol Myers Squibb, Division of Immunology and Fibrosis Development, Princeton, United States;(11)Bristol Myers Squibb, Department of Immunology and Fibrosis Development, Princeton, United States;(12)University of Chicago Medicine, Inflammatory Bowel Disease Center, Chicago, United States;

Notice: Undefined property: stdClass::$icfcat in /home/elearec6/www.gtntest-e-learning.ecco-ibd.eu/moodleneu/blocks/exalib/renderer.php on line 255

Notice: Undefined variable: catt in /home/elearec6/www.gtntest-e-learning.ecco-ibd.eu/moodleneu/blocks/exalib/renderer.php on line 269
DOP43: Rapidity of ozanimod-induced symptomatic response and remission in patients with moderately to severely active Ulcerative Colitis: Results from the induction period of True NorthECCO'22
Year: 2022
Authors: Siegmund, B.(1);Axelrad, J.(2);Pondel, M.(3);Osterman, M.T.(3);Ahmad, H.A.(3);Memaj, A.(3);Regueiro, M.(4);Armuzzi, A.(5);Afzali, A.(6);
(1)Charité – Universitätsmedizin Berlin, Gastroenterology, Berlin, Germany;(2)NYU Langone Health, Gastroenterology, New York, United States;(3)Bristol Myers Squibb, Department of Immunology and Fibrosis Development, Princeton, United States;(4)Cleveland Clinic, Gastroenterology, Cleveland, United States;(5)Fondazione Policlinico A. Gemelli IRCCS, Catholic University of Rome, Rome, Italy;(6)The Ohio State University, Wexner Medical Center, Columbus, United States;

Notice: Undefined property: stdClass::$icfcat in /home/elearec6/www.gtntest-e-learning.ecco-ibd.eu/moodleneu/blocks/exalib/renderer.php on line 255

Notice: Undefined variable: catt in /home/elearec6/www.gtntest-e-learning.ecco-ibd.eu/moodleneu/blocks/exalib/renderer.php on line 269
DOP44: Long-term use of ozanimod in patients with moderately to severely active Ulcerative ColitisECCO'22
Year: 2022
Authors: Danese, S.(1);Colombel, J.F.(2);Ponich, T.(3);Jovanovic, I.(4);Bossuyt, P.(5);Longman, R.(6);Alekseeva, O.(7);Petersen, A.(8);Chitkara, D.(8);Marta, C.(8);Charles, L.(8);Rubin, D.T.(9);Afzali, A.(10);Loftus, E.V.(11);Wolf, D.C.(12);
(1)IRCCS San Raffaele Hospital, Gastroenterology, Milan, Italy;(2)Icahn School of Medicine at Mount Sinai, Gastroenterology, New York, United States;(3)Western University, Gastroenterology, London, Canada;(4)University Hospital Medical Centre Bezanijska Kosa, Gastroenterology, Belgrade, Serbia;(5)Imelda GI Clinical Research Center- Imelda General Hospital, Gastroenterology, Bonheiden, Belgium;(6)Jill Roberts Center for Inflammatory Bowel Disease- Weill Cornell Medicine, Gastroenterology, New York, United States;(7)Nizhny Novgorod Regional Clinical Hospital, Gastroenterology, Nizhny Novgorod, Russian Federation;(8)Bristol Myers Squibb, Department of Fibrosis and Immunology, Princeton, United States;(9)University of Chicago Medicine Inflammatory Bowel Disease Center, Inflammatory Bowel Disease Center, Chicago, United States;(10)The Ohio State University Wexner Medical Center, Gastroenterology, Columbus, United States;(11)Mayo Clinic College of Medicine, Division of Gastroenterology and Hepatology, Rochester, United States;(12)Atlanta Gastroenterology Associates, Center for Crohn’s Disease & Ulcerative Colitis, Atlanta, United States;